cro.directory
← Compare landing

PSI vs Linical

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryPSILinical
SummaryPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.Global, award-winning CRO guiding clinical development from early-phase research to large-scale global studies with 90% client retention.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Regulatory Affairs
Modalities
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Respiratory
  • Gastroenterology
  • Nephrology
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
Phases
  • Phase II
  • Phase III
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Osaka, Osaka, Osaka, Japan
  • Global Operations
  • Japan, Japan, Japan
CertificationsData not yet provided.Data not yet provided.

Find similar companies

PSI alternatives · Linical alternatives

Markdown mirror: /compare/appian/linical.md